400

The story unfolds

thestory

Milan (Italy), early 90s.

A group of dedicated Italian and European doctors, all with substantial homeopathic, clinical and research experience in common, glimpse the possibility of using homeopathic doses of biological molecules such as Neuropeptides, Hormones, Cytokines and Growth Factors: which aptly defines the new frontier in homeopathy.

Then, with the support of GUNA S.p.a.’s Scientific Department – the leading Italian pharmaceutical company in homeopathy – the researchers were brought together under one umbrella to exchange ideas, to research further and to develop advanced and innovative concepts. So, a new common ground emerged – and the achievements in the field of Psycho-Neuro-Endocrine-Immunology (P.N.E.I.) created a climate for innovation from which springs progressive and unique applications of low dose medicine in the form of Physiological Regulation Therapy (The GUNA Method).